Case Study: Acute Myocardial Infarction in a Diabetic Patient

Evidence-based management of an anterior wall STEMI in a middle-aged male with Type 2 Diabetes, Hypertension, and Dyslipidemia. This detailed write-up reflects Aleta’s clinical accuracy, regulatory clarity, and patient-centered communication.

Patient Overview

Patient: Mr. R.K., 45-year-old male
Presentation: Sudden severe chest pain radiating to left arm and jaw
History: Type 2 Diabetes Mellitus (7 years), Hypertension, Dyslipidemia; ex-smoker (quit 2 years ago); sedentary lifestyle

Adjoined Complications

  • Type 2 Diabetes Mellitus — poorly controlled (HbA1c 7.9%)
  • Hypertension
  • Dyslipidemia
  • Mild obesity (BMI 29 kg/m²)

Investigations

  • ECG: ST-segment elevation in V1–V4 (anterior leads)
  • Cardiac biomarkers: Elevated troponin
  • Echocardiogram: Anterior wall hypokinesia; LVEF ~40%

Diagnosis

Acute Anterior Wall Myocardial Infarction (STEMI) due to obstruction in the Left Anterior Descending (LAD) artery.

Management

Reperfusion

Emergency percutaneous coronary intervention (PCI) with stent placement.

Medications

  • Dual Antiplatelet Therapy: Aspirin + Ticagrelor
  • High-intensity statin: Atorvastatin 80 mg daily
  • ACE inhibitor: Lisinopril 10–20 mg daily
  • Beta-blocker: Metoprolol 25–50 mg twice daily
  • Glycemic control: Metformin + SGLT2 inhibitor

Lifestyle Modifications

  • Dietary pattern: Low-fat, low-sugar, high-fiber (DASH/Mediterranean)
  • Activity: Walking 30 minutes/day, 5 days/week after cardiac clearance
  • Avoid smoking, alcohol, and high-salt foods
  • Routine monitoring: BP, blood glucose, lipid profile
  • Enroll in a structured cardiac rehabilitation program

Precautions & Follow-up

  • Strict adherence to all medications, especially dual antiplatelet therapy
  • Regular follow-up with cardiologist and diabetologist
  • Urgent reporting of new chest pain, breathlessness, or edema
  • Weight management and stress reduction practices

References

  • ESC Guidelines for the Management of Acute Myocardial Infarction (2023).
  • American Diabetes Association — Standards of Care in Diabetes (2025).
  • NICE Guideline NG185 — Secondary Prevention in ACS (2023).